Yu-Ning Teng1, Yingzi Wang2, Pei-Ling Hsu3, Guang Xin3, Yu Zhang4, Susan L Morris-Natschke5, Masuo Goto3, Kuo-Hsiung Lee6. 1. Natural Products Research Laboratories, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA; Department of Pharmacy, College of Pharmacy, China Medical University, 91 Hsueh-Shih Road, Taichung 40402, Taiwan. 2. Natural Products Research Laboratories, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA; College of Traditional Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, People's Republic of China. Electronic address: wangyzi@sina.com. 3. Natural Products Research Laboratories, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA. 4. College of Traditional Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, People's Republic of China. 5. Natural Products Research Laboratories, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA. Electronic address: susan_natschke@unc.edu. 6. Natural Products Research Laboratories, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA; Chinese Medicine Research and Development Center, China Medical University and Hospital, 2 Yuh-Der Road, Taichung 40447, Taiwan. Electronic address: khlee@email.unc.edu.
Abstract
BACKGROUND: The seeds of Euphorbia lathyris are used in traditional Chinese medicines for the treatment of various medical conditions. E. lathyris contains many natural diterpenes with a lathyrane skeleton. PURPOSE AND STUDY DESIGN: Five lathyrane-type diterpenoids named Euphorbia factors L1, L2, L3, L8, and L9 (1-5), were investigated for cytotoxicity against A549, MDA-MB-231, KB, and MCF-7 cancer cell lines and the KB-VIN multidrug resistant (MDR) cancer cell line. Also, a tetraol derivative (6) of Euphorbia factor L2 (2) was synthesized to assess the effect of hydroxy moieties. METHODS: An ethanolic extract of seeds of Euphorbia lathyris was prepared and separated into petroleum ether, EtOAc, n-butanol, and n-hexane extracts. The natural diterpenes were isolated by using silica gel and Sephadex LH-20 column chromatography as well as preparative thin-layer chromatography. Saponification of 2 gave tetraol derivative 6. Cytotoxic activity was determined by the sulforhodamine B (SRB) colorimetric assay. Mechanism of action studies focused on the impact of compounds on the cell cycle progression as well as cell morphology. RESULTS: Compound 5 exhibited the strongest cytotoxicity against all cell lines, while compound 2 showed selectivity against KB-VIN. In cells treated with 3 and 5, accumulation of G1 to early S phase cells was obvious, while no effect was seen on G2/M phase. CONCLUSION: Analysis of the screening data compared with compound structures suggested that the substitutions at C-3, C-5, C-7, and C-15 are critical for cytotoxicity, as well as cell type-selectivity. Furthermore, results of cytotoxic mechanism analysis demonstrated for the first time that compounds 3 and 5 disrupted normal cell cycle progression, whereas compounds 2‒5 induced obvious actin filament aggregation, as well as partial interference of the microtubule network.
BACKGROUND: The seeds of Euphorbia lathyris are used in traditional Chinese medicines for the treatment of various medical conditions. E. lathyris contains many natural diterpenes with a lathyrane skeleton. PURPOSE AND STUDY DESIGN: Five lathyrane-type diterpenoids named Euphorbia factors L1, L2, L3, L8, and L9 (1-5), were investigated for cytotoxicity against A549, MDA-MB-231, KB, and MCF-7 cancer cell lines and the KB-VIN multidrug resistant (MDR) cancer cell line. Also, a tetraol derivative (6) of Euphorbia factor L2 (2) was synthesized to assess the effect of hydroxy moieties. METHODS: An ethanolic extract of seeds of Euphorbia lathyris was prepared and separated into petroleum ether, EtOAc, n-butanol, and n-hexane extracts. The natural diterpenes were isolated by using silica gel and Sephadex LH-20 column chromatography as well as preparative thin-layer chromatography. Saponification of 2 gave tetraol derivative 6. Cytotoxic activity was determined by the sulforhodamine B (SRB) colorimetric assay. Mechanism of action studies focused on the impact of compounds on the cell cycle progression as well as cell morphology. RESULTS: Compound 5 exhibited the strongest cytotoxicity against all cell lines, while compound 2 showed selectivity against KB-VIN. In cells treated with 3 and 5, accumulation of G1 to early S phase cells was obvious, while no effect was seen on G2/M phase. CONCLUSION: Analysis of the screening data compared with compound structures suggested that the substitutions at C-3, C-5, C-7, and C-15 are critical for cytotoxicity, as well as cell type-selectivity. Furthermore, results of cytotoxic mechanism analysis demonstrated for the first time that compounds 3 and 5 disrupted normal cell cycle progression, whereas compounds 2‒5 induced obvious actin filament aggregation, as well as partial interference of the microtubule network.
Authors: Judit Hohmann; Joseph Molnár; Dóra Rédei; Ferenc Evanics; Peter Forgo; Alajos Kálmán; Gyula Argay; Pál Szabó Journal: J Med Chem Date: 2002-06-06 Impact factor: 7.446
Authors: Gabriella Corea; Ernesto Fattorusso; Virginia Lanzotti; Orazio Taglialatela-Scafati; Giovanni Appendino; Mauro Ballero; Pierre-Noël Simon; Charles Dumontet; Attilio Di Pietro Journal: J Med Chem Date: 2003-07-17 Impact factor: 7.446
Authors: Giovanni Appendino; Carla Della Porta; Gwenaëlle Conseil; Olov Sterner; Enrico Mercalli; Charles Dumontet; Attilio Di Pietro Journal: J Nat Prod Date: 2003-01 Impact factor: 4.050
Authors: Bahare Salehi; Marcello Iriti; Sara Vitalini; Hubert Antolak; Ewelina Pawlikowska; Dorota Kręgiel; Javad Sharifi-Rad; Sunday I Oyeleye; Adedayo O Ademiluyi; Katarzyna Czopek; Mariola Staniak; Luísa Custódio; Ericsson Coy-Barrera; Antonio Segura-Carretero; María de la Luz Cádiz-Gurrea; Raffaele Capasso; William C Cho; Ana M L Seca Journal: Biomolecules Date: 2019-08-02